Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_assertion type Assertion NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_head.
- NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_assertion description "[Together, these observations suggest that activation of CRLF2 expression, mutation of JAK kinases, and alterations of IKZF1 cooperate to promote B-cell leukemogenesis and identify these pathways as important therapeutic targets in this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_provenance.
- NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_assertion evidence source_evidence_literature NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_provenance.
- NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_assertion SIO_000772 20139093 NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_provenance.
- NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_assertion wasDerivedFrom befree-2016 NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_provenance.
- NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_assertion wasGeneratedBy ECO_0000203 NP792352.RAfHpjsdUfVejhoNSPvvzmrrrlJ5EsQEffQXV18pu16O8130_provenance.